Federico Verga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Federico Verga has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Marcelo Barbato
Unidad de Cuidados Intensivos del Hospital Maciel, ASSE, Montevideo, Uruguay
3 shared publications Mariela Vieytes
2 shared publications- Pedro Grille
Hospital Maciel, Hospital de Clinicas
2 shared publications A. Benabdallah
Université de Provence, LATP
1 shared publication- Alberto Biestro
Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Centro de Tratamiento Intensivo, Ex Profesor Director
1 shared publication - Ana Gruss
Universidad de la República (Udelar), Facultad de Medicina, Instituto del Tórax, Unidad académica de Neumología, Montevideo, Uruguay
1 shared publication
Latest Publications
- Open Access
- 27 June 2025
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 17 (2) , 139-148
Crisis asmática severa en la unidad de cuidados intensivos. Características clínicas, epidemiológicas y evolutivas.
Introduction: Asthma is a chronic inflammatory disease that causes respiratory exacerbations that can be life threatening. Knowing the characteristics and triggers of patients with severe attacks is essential for proper management. Methods: This retrospective, observational and descriptive study included patients over 18 years old who were admitted to the Intensive Care Unit of Maciel Hospital (Montevideo, Uruguay) with a diagnosis of severe asthma crisis between June 1, 2016, and May 31, 2023. Results: 61 patients were included, with a mean age of 47.8 ± 16.5 years. 92% had prior emergency consultations and 55.7% had previously required admission to intensive care. 93,4% were not immunized and 80.3% had no prior pulmonary follow-up. All patients required ventilatory support, 48 (78.7%) invasively and 13 (21.3%) non-invasively. Infections were the main cause of decompensation in 49.3% of cases, with viruses being the most common etiology (63.3%). The main complications were infections (13.1%), followed by hypokalemia (11.5%), cardiorespiratory arrest (8.2%), quadriparesis (4.9%) and pneumothorax (4.9%). The median length of stay was 5 days, with only 1 patient dying (mortality rate of 1.6%). 16.4% required readmission to intensive care within 6 months. Conclusions: Most patients are young, with few follow-ups during stable phases and low immunization rates. They have high ventilatory support requirements but a short ICU stay and low mortality. Achieving adequate control and treatment adherence during stable phases is essential to prevent severe crises.
- 27 June 2025
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 17 (2) , 139-148
Open AccessCrisis asmática severa en la unidad de cuidados intensivos. Características clínicas, epidemiológicas y evolutivas.
Introduction: Asthma is a chronic inflammatory disease that causes respiratory exacerbations that can be life threatening. Knowing the characteristics and triggers of patients with severe attacks is essential for proper management. Methods: This retrospective, observational and descriptive study included patients over 18 years old who were admitted to the Intensive Care Unit of Maciel Hospital (Montevideo, Uruguay) with a diagnosis of severe asthma crisis between June 1, 2016, and May 31, 2023. Results: 61 patients were included, with a mean age of 47.8 ± 16.5 years. 92% had prior emergency consultations and 55.7% had previously required admission to intensive care. 93,4% were not immunized and 80.3% had no prior pulmonary follow-up. All patients required ventilatory support, 48 (78.7%) invasively and 13 (21.3%) non-invasively. Infections were the main cause of decompensation in 49.3% of cases, with viruses being the most common etiology (63.3%). The main complications were infections (13.1%), followed by hypokalemia (11.5%), cardiorespiratory arrest (8.2%), quadriparesis (4.9%) and pneumothorax (4.9%). The median length of stay was 5 days, with only 1 patient dying (mortality rate of 1.6%). 16.4% required readmission to intensive care within 6 months. Conclusions: Most patients are young, with few follow-ups during stable phases and low immunization rates. They have high ventilatory support requirements but a short ICU stay and low mortality. Achieving adequate control and treatment adherence during stable phases is essential to prevent severe crises.
- 3 June 2025
- Published by Elsevier in Journal of Critical Care
- Vol. 89, 155131
Post-extubation polyuria: characterization of an underrecognized phenomenon in a proof-of-concept study.
- 3 June 2025
- Published by Elsevier in Journal of Critical Care
- Vol. 89, 155131
Post-extubation polyuria: characterization of an underrecognized phenomenon in a proof-of-concept study.
- 15 July 2024
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 40 (3)
Prevalencia de consumo de cocaína y cannabis en pacientes traumatizados ingresados a medicina intensiva
La Revista Médica del Uruguay (RMU) es la publicación científica oficial del Sindicato Médico del Uruguay (SMU) y fue fundada en agosto de 1974. Publica artículos referentes a temas en el ámbito de la medicina.
- 15 July 2024
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 40 (3)
Prevalencia de consumo de cocaína y cannabis en pacientes traumatizados ingresados a medicina intensiva
La Revista Médica del Uruguay (RMU) es la publicación científica oficial del Sindicato Médico del Uruguay (SMU) y fue fundada en agosto de 1974. Publica artículos referentes a temas en el ámbito de la medicina.
- Open Access
- 13 September 2022
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 14 (3)
Concordancia del antígeno de galactomanano en lavado broncoalveolar broncoscópico y mini lavado broncoalveolar a ciegas
Introduction: viral pneumonias increase the susceptibility to develop fungal secondary infections. With COVID-19 pandemic, multiple cases of invasive pulmonary aspergillosis associated with COVID-19 (PAAC) have been reported, increasing mortality. It is not recommended to perform bronchoscopy during COVID-19 illness given the risk of aerosolization, so new techniques such as mini bronchoalveolar lavage (BAL) emerge. The necessity to perform a validating task for the galactomannan (GM) measurement in samples obtained through mini-BAL emerges from the absence of cutting points for the GM antigen positivity in respiratory samples non obtained by bronchoscopy. Aim: to validate the concordance of GM measurement in respiratory samples obtained through mini-BAL and BAL by bronchoscopy. Material and methods: observational and analytical prospective study. Patients admitted to intensive care unit with suspected PAAC who were asked to obtain respiratory samples for MG study were included. In all the cases, BAL and mini-BAL samples were obtained in one same procedure. It was considered positive GM with a value higher than 1. Results: 11 patients were studied, 6 (54.5%) cases were diagnosed positive for PAAC through bronchoscopic BAL. The mini-BAL sensitivity was 33% and the specificity 100%; predictive positive value 100% and negative predictive value 55%. The concordance correlation coefficient was 0,28% (IC -0,078 a 0,57), which showed a poor concordance between both methods. Conclusion: The GM test through mini-BAL could prove to be a fine confirmatory method, while a negative result does not discard PAAC. Introducción: las neumonías virales aumentan la susceptibilidad de sobreinfecciones fúngicas. Con la pandemia COVID-19, se reportaron múltiples casos de aspergilosis pulmonar invasiva asociada a COVID-19 (CAPA), lo que aumentó la mortalidad. No se recomienda realizar broncoscopía cursando COVID-19 dado el riesgo de aerosolización. Surgen entonces nuevas técnicas como el mini lavado broncoalveolar (LBA) a ciegas. Al no existir puntos de corte para la positividad del antígeno de galactomanano (GM) en muestras respiratorias no obtenidas por broncoscopía, surge la necesidad de validar la medición de GM en muestras obtenidas mediante mini LBA a ciegas. Objetivo: valorar la concordancia de medición de GM en muestras respiratorias obtenidas mediante mini LBA a ciegas y LBA por broncoscopia. Materiales y métodos: realizamos un estudio prospectivo, observacional y analítico, incluyendo pacientes ingresados en cuidados intensivos con sospecha de CAPA, que requirieron obtención de muestras respiratorias para estudio de GM. En todos se obtuvieron muestras de LBA y mini LBA a ciegas en un mismo procedimiento. Se consideró positivo GM mayor a 1. Resultados: se estudiaron 11 pacientes, se diagnosticaron 6 (54.5%) casos positivos para CAPA mediante LBA broncoscópico. La sensibilidad del mini LBA fue 33% y la especificidad 100%; valor predictivo positivo 100% y valor predictivo negativo 55%. El coeficiente de correlación de concordancia fue de 0,28 (IC -0,078 a 0,57), lo que mostró pobre concordancia entre ambos métodos. Conclusiones: el test de GM por mini LBA podría resultar un buen método confirmatorio, mientras que un resultado negativo no descarta CAPA.
- 13 September 2022
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 14 (3)
Open AccessConcordancia del antígeno de galactomanano en lavado broncoalveolar broncoscópico y mini lavado broncoalveolar a ciegas
Introduction: viral pneumonias increase the susceptibility to develop fungal secondary infections. With COVID-19 pandemic, multiple cases of invasive pulmonary aspergillosis associated with COVID-19 (PAAC) have been reported, increasing mortality. It is not recommended to perform bronchoscopy during COVID-19 illness given the risk of aerosolization, so new techniques such as mini bronchoalveolar lavage (BAL) emerge. The necessity to perform a validating task for the galactomannan (GM) measurement in samples obtained through mini-BAL emerges from the absence of cutting points for the GM antigen positivity in respiratory samples non obtained by bronchoscopy. Aim: to validate the concordance of GM measurement in respiratory samples obtained through mini-BAL and BAL by bronchoscopy. Material and methods: observational and analytical prospective study. Patients admitted to intensive care unit with suspected PAAC who were asked to obtain respiratory samples for MG study were included. In all the cases, BAL and mini-BAL samples were obtained in one same procedure. It was considered positive GM with a value higher than 1. Results: 11 patients were studied, 6 (54.5%) cases were diagnosed positive for PAAC through bronchoscopic BAL. The mini-BAL sensitivity was 33% and the specificity 100%; predictive positive value 100% and negative predictive value 55%. The concordance correlation coefficient was 0,28% (IC -0,078 a 0,57), which showed a poor concordance between both methods. Conclusion: The GM test through mini-BAL could prove to be a fine confirmatory method, while a negative result does not discard PAAC. Introducción: las neumonías virales aumentan la susceptibilidad de sobreinfecciones fúngicas. Con la pandemia COVID-19, se reportaron múltiples casos de aspergilosis pulmonar invasiva asociada a COVID-19 (CAPA), lo que aumentó la mortalidad. No se recomienda realizar broncoscopía cursando COVID-19 dado el riesgo de aerosolización. Surgen entonces nuevas técnicas como el mini lavado broncoalveolar (LBA) a ciegas. Al no existir puntos de corte para la positividad del antígeno de galactomanano (GM) en muestras respiratorias no obtenidas por broncoscopía, surge la necesidad de validar la medición de GM en muestras obtenidas mediante mini LBA a ciegas. Objetivo: valorar la concordancia de medición de GM en muestras respiratorias obtenidas mediante mini LBA a ciegas y LBA por broncoscopia. Materiales y métodos: realizamos un estudio prospectivo, observacional y analítico, incluyendo pacientes ingresados en cuidados intensivos con sospecha de CAPA, que requirieron obtención de muestras respiratorias para estudio de GM. En todos se obtuvieron muestras de LBA y mini LBA a ciegas en un mismo procedimiento. Se consideró positivo GM mayor a 1. Resultados: se estudiaron 11 pacientes, se diagnosticaron 6 (54.5%) casos positivos para CAPA mediante LBA broncoscópico. La sensibilidad del mini LBA fue 33% y la especificidad 100%; valor predictivo positivo 100% y valor predictivo negativo 55%. El coeficiente de correlación de concordancia fue de 0,28 (IC -0,078 a 0,57), lo que mostró pobre concordancia entre ambos métodos. Conclusiones: el test de GM por mini LBA podría resultar un buen método confirmatorio, mientras que un resultado negativo no descarta CAPA.
- Open Access
- 6 August 2022
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 38 (2)
Utilidad del panel de PCR multiplex en el diagnóstico microbiológico temprano y adecuación antimicrobiana en pacientes críticos con neumonía
- 6 August 2022
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 38 (2)
Open AccessUtilidad del panel de PCR multiplex en el diagnóstico microbiológico temprano y adecuación antimicrobiana en pacientes críticos con neumonía
- Open Access
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 79 (9) , 781-788
Individual variation of tentorial notch morphometry in a series of neurocritical patients
Background: Cadaveric studies on humans have shown anatomical variabilities in the morphometric characteristics of the tentorial notch. These anatomical variations could influence the worsening of neurocritical patients. Objectives: 1) To investigate the morphometric characteristics of the tentorial notch in neurocritical patients using computed tomography (CT); 2) To investigate the correlation between tentorial notch measurements by CT and by magnetic resonance imaging (MRI); and 3) To analyze the individual variability of the tentorial notch anatomy seen in neurocritical patients. Methods: Prospective series of neurocritical patients was examined. An imaging protocol for measurements was designed for CT and MRI. The level of the agreement of the measurements from CT and MR images was established. According to the measurements found, patients were divided into different types of tentorial notch. Results: We studied 34 neurocritical patients by CT and MRI. Measurements of the tentorial notch via CT and MRI showed significant agreement: concordance correlation coefficient of 0.96 for notch length and 0.85 for maximum width of tentorial notch. Classification of tentorial notch measurements according to the criteria established by Adler and Milhorat, we found the following: 15 patients (58%) corresponded to a "short" subtype; 7 (21%) to "small"; 3 (9%) to "narrow"; 2 (6%) to "wide"; 2 (6%) to “large”; 1 (3%) to “long”; and 4 (12%) to "typical". Conclusions: The anatomical variability of the tentorial notch could be detected in vivo by means of CT scan and MRI. Good agreement between the measurements made using these two imaging methods was found.
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 79 (9) , 781-788
Open AccessIndividual variation of tentorial notch morphometry in a series of neurocritical patients
Background: Cadaveric studies on humans have shown anatomical variabilities in the morphometric characteristics of the tentorial notch. These anatomical variations could influence the worsening of neurocritical patients. Objectives: 1) To investigate the morphometric characteristics of the tentorial notch in neurocritical patients using computed tomography (CT); 2) To investigate the correlation between tentorial notch measurements by CT and by magnetic resonance imaging (MRI); and 3) To analyze the individual variability of the tentorial notch anatomy seen in neurocritical patients. Methods: Prospective series of neurocritical patients was examined. An imaging protocol for measurements was designed for CT and MRI. The level of the agreement of the measurements from CT and MR images was established. According to the measurements found, patients were divided into different types of tentorial notch. Results: We studied 34 neurocritical patients by CT and MRI. Measurements of the tentorial notch via CT and MRI showed significant agreement: concordance correlation coefficient of 0.96 for notch length and 0.85 for maximum width of tentorial notch. Classification of tentorial notch measurements according to the criteria established by Adler and Milhorat, we found the following: 15 patients (58%) corresponded to a "short" subtype; 7 (21%) to "small"; 3 (9%) to "narrow"; 2 (6%) to "wide"; 2 (6%) to “large”; 1 (3%) to “long”; and 4 (12%) to "typical". Conclusions: The anatomical variability of the tentorial notch could be detected in vivo by means of CT scan and MRI. Good agreement between the measurements made using these two imaging methods was found.
- Open Access
- 10 August 2011
- Published by Walter de Gruyter GmbH in Oncologie
- Vol. 13 (8) , 528-533
Modélisation du risque d’évolution métastatique chez les patients supposés avoir une maladie localisée
Classification of cancer as localized or metastatic disease remains the mainstay for determining the best therapeutic strategy to be undertaken at bedside. Although simple, this classification may underestimate the risk of undetectable, early metastatic stages. Many studies have been performed to identify prognostic biomarkers for evaluating the risk of metastatic relapse in patients with apparently localized disease. Here, we have developed an original mathematical model designed to calculate a Metastatic Index. This Metastatic Index should enable to better predict the risk of invasive cancer, even when it does not show with standard imaging techniques. Further validation steps are ongoing, both in tumor-bearing animals and as part of retrospective comparisons with clinical data. This new tool should help the clinician to undertake systemic treatment at the earliest stages of the disease, thus allowing a better efficacy eventually. La stratégie de traitement d’une tumeur solide repose fondamentalement sur le classement initial entre maladie localisée ou avancée. Or, il est possible que des états métastatiques précoces ne soient pas mis en évidence lors des bilans d’extension. Ce risque implicitement reconnu justifierait pourtant l’usage de thérapies adjuvantes après traitement radical de type exérèse chirurgicale. Un grand nombre de travaux ont déjà été réalisés afin d’identifier des marqueurs pronostiques permettant de préciser ce risque invasif chez des patients dont la maladie était apparemment localisée. Dans ce contexte, notre étude, basée sur une modélisation mathématique originale, présente un nouveau marqueur, l’index métastatique (IM), permettant de donner une estimation du nombre et de la taille des métastases en fonction du temps. À terme, cette technologie pourrait fournir un nouvel outil décisionnel précieux permettant de prédire le risque d’évolution métastatique et éclairer au mieux le clinicien sur l’intérêt d’un éventuel traitement adjuvant.
- 10 August 2011
- Published by Walter de Gruyter GmbH in Oncologie
- Vol. 13 (8) , 528-533
Open AccessModélisation du risque d’évolution métastatique chez les patients supposés avoir une maladie localisée
Classification of cancer as localized or metastatic disease remains the mainstay for determining the best therapeutic strategy to be undertaken at bedside. Although simple, this classification may underestimate the risk of undetectable, early metastatic stages. Many studies have been performed to identify prognostic biomarkers for evaluating the risk of metastatic relapse in patients with apparently localized disease. Here, we have developed an original mathematical model designed to calculate a Metastatic Index. This Metastatic Index should enable to better predict the risk of invasive cancer, even when it does not show with standard imaging techniques. Further validation steps are ongoing, both in tumor-bearing animals and as part of retrospective comparisons with clinical data. This new tool should help the clinician to undertake systemic treatment at the earliest stages of the disease, thus allowing a better efficacy eventually. La stratégie de traitement d’une tumeur solide repose fondamentalement sur le classement initial entre maladie localisée ou avancée. Or, il est possible que des états métastatiques précoces ne soient pas mis en évidence lors des bilans d’extension. Ce risque implicitement reconnu justifierait pourtant l’usage de thérapies adjuvantes après traitement radical de type exérèse chirurgicale. Un grand nombre de travaux ont déjà été réalisés afin d’identifier des marqueurs pronostiques permettant de préciser ce risque invasif chez des patients dont la maladie était apparemment localisée. Dans ce contexte, notre étude, basée sur une modélisation mathématique originale, présente un nouveau marqueur, l’index métastatique (IM), permettant de donner une estimation du nombre et de la taille des métastases en fonction du temps. À terme, cette technologie pourrait fournir un nouvel outil décisionnel précieux permettant de prédire le risque d’évolution métastatique et éclairer au mieux le clinicien sur l’intérêt d’un éventuel traitement adjuvant.